Tag: Philadelphia

Imvax Charges Ahead with Phase IIb Glioblastoma Trial

Philadelphia-based Imvax recently announced it had dosed the first patient in it...

SVB Collapse Appears to Only Have Minor Ripples for Bio...

While the impact for this event might not be as bad as anticipated, it sends a w...

In Conversation With Gilda D'Incerti, Founder and CEO o...

In celebration of International Women's Day, BioBuzz caught up with D'Incerti to...

In a Recent M&A Desert, Philly Proves to Be an Oasis

More on the latest Philly M&AS: Adaptimmune and TCR2; Kite and Tmunity.

A Mother’s Journey, a Biotech for Her Daughter

Michelle Teng, Ph.D., says that her eldest daughter, Sofia, “had a very normal c...